Extra-pleural pneumonectomy: How I teach it
- PMID: 39478891
- PMCID: PMC11518929
- DOI: 10.1016/j.xjtc.2024.06.018
Extra-pleural pneumonectomy: How I teach it
Keywords: extra-pleural pneumonectomy; mesothelioma.
Conflict of interest statement
The authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.
Figures
References
-
- Baas P., Scherpereel A., Nowak A.K., et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet. 2021;397(10272):375–386. - PubMed
-
- Chu Q., Perrone F., Greillier L., et al. Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial. Lancet. 2023;402(10419):2295–2306. - PubMed
-
- Donahoe L., de Perrot M. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. Thorac Surg Clin. 2020;30:461–471. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
